CLRB
CLRB
NASDAQ · Biotechnology

Cellectar Biosciences Inc

$3.04
+0.22 (+7.80%)
As of Feb 8, 2:28 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 1.64M 1.62M 1.37M
Net Income -247,177 -249,222 -229,259
EPS
Profit Margin -15.1% -15.4% -16.8%
Rev Growth +20.7% +12.0% +3.1%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 725.4K 769.8K 655.7K
Total Equity 8.16M 7.21M 8.65M
D/E Ratio 0.09 0.11 0.08
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -331,691 -310,875 -283,649
Free Cash Flow -127,219 -197,557 -123,470